Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations-Reference-Cited by-同舟云学术

Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations

Published:2022-07-14 Issue:7 Volume:5 Page:e2222089
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Haymart Brian¹,Barnes Geoffrey D.¹,Kong Xiaowen¹,Ali Mona²,Kline-Rogers Eva¹,DeCamillo Deborah¹,Kaatz Scott³

Affiliation:

1. Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor

2. Department of Heart and Vascular Services, Beaumont Hospital, Royal Oak, Michigan

3. Division of Hospital Medicine, Henry Ford Hospital, Detroit, Michigan

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2794213/haymart_2022_ld_220143_1657213565.65871.pdf

Reference6 articles.

1. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.;Hindricks;Eur Heart J,2021

2. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report.;Lip;Chest,2018

3. Practical management of anticoagulation in patients with atrial fibrillation.;Kovacs;J Am Coll Cardiol,2015

4. The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience.;Barnes;Thromb Res,2014

5. Anticoagulation changes following major and clinically relevant nonmajor bleeding events in non-valvular atrial fibrillation patients.;Feldeisen;J Pharm Pract,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions between antiepileptic drugs and direct oral anticoagulants for primary and secondary stroke prevention;Expert Opinion on Drug Metabolism & Toxicology;2024-05-03

2. Drug-drug interactions with direct oral anticoagulants for the prevention of ischemic stroke and embolism in atrial fibrillation: a narrative review of adverse events;Expert Review of Clinical Pharmacology;2023-03-07

3. Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants;Clinical and Applied Thrombosis/Hemostasis;2023-01

4. Frequency and clinical outcomes of pharmacist-driven switching from warfarin to direct oral anticoagulants in an underserved patient population: A retrospective cohort study;American Journal of Health-System Pharmacy;2022-12-16